Infinity Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Infinity Pharmaceuticals

27/07/2021 14:03

* Infinity Pharmaceuticals Inc  INFI.OQ  reported a quarterly
adjusted loss of 13 cents​​ per share for the quarter ended in
June. The mean expectation of seven analysts for the quarter was
for a loss of 14 cents per share.
* Revenue rose 42.2% to $512.00 thousand from a year ago; 
analysts expected $279.33 thousand. 
* Infinity Pharmaceuticals Inc's reported EPS for the quarter
was a loss of 13 cents​.
* The mean earnings estimate of analysts had fallen by
about 7.2% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Infinity Pharmaceuticals Inc shares had fallen by 25.8% this
quarter and gained 4.7% so far this year.
* The company reported a quarterly loss of $11.27 million.
* Wall Street's median 12-month price target for Infinity
Pharmaceuticals Inc is $8.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated July 27 at 01:03 p.m.  ​All
figures in US dollars unless otherwise stated